Is Option B+ the best choice? Authors' reply

Lancet. 2013 Apr 13;381(9874):1273-4. doi: 10.1016/S0140-6736(13)60835-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Retroviral Agents / administration & dosage*
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*

Substances

  • Anti-Retroviral Agents